Report Scope:
The study scope includes core synthetic biology products (e.g., oligonucleotides, synthetic genes, BioBrick parts, delivery plasmids, chassis organisms, synthetic cells, cell-based and cell-free production systems), enabling technologies (e.g., DNA sequencing, DNA synthesis, gene editing, bioinformatics, specialty media) and enabled technologies (e.g., healthcare, industrial chemicals, consumer products, food and beverage, agriculture) that are already commercialized or are forecast to be commercialized through 2029.

Key synthetic biology technologies and products are analyzed to determine present and future market status, as well as forecasted growth from 2024 through 2029. An in-depth discussion of strategic alliances, industry structures, competitive dynamics, patents, and market-driving forces is also provided.

The key player examines the synthetic biology industry by market segment, including DNA sequencing, DNA synthesis, gene editing, synthetic biology foundries, and software. The market is also analyzed by end users, including agriculture, consumer products, cosmetics and skin care, food and beverage, healthcare, and industrial chemicals.

By geographical region, the market is divided into four regions: North America, Europe, Asia-Pacific, and Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029.

Report Includes:

  • 50 data tables and 45 additional tables
  • An analysis of the global markets for synthetic biology products and technologies
  • Analyses of global market trends, with market revenue data from 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
  • Estimates of the current market size and revenue prospects, along with market share analysis by product type, end-user industry and region
  • Facts and figures pertaining to the market drivers and challenges, innovations, technologies, industry regulations, and the influence of macroeconomic factors


- Identification of core synthetic biology products, key enabling technologies, commercial opportunities for product development, and competitive strategies

  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, the ESG practices of leading companies and their ESG scores
  • An analysis of patents granted for synthetic biology technologies, liquid biopsy and sequencing, and gene editing
  • Analysis of the industry structure, including company market shares, strategic alliances, M&A activity and venture funding outlook
  • Profiles of the market leaders, including Ginkgo Bioworks, Amyris, Twist Bioscience, Codexis Inc., and Thermo Fisher Scientific Inc.